| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034891824 |
| P356 | DOI | 10.1186/S12969-016-0082-8 |
| P3181 | OpenCitations bibliographic resource ID | 2093656 |
| P932 | PMC publication ID | 4845429 |
| P698 | PubMed publication ID | 27112923 |
| P2093 | author name string | Despina Eleftheriou | |
| Paul A Brogan | |||
| P2860 | cites work | Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate | Q36692302 |
| Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report | Q37107147 | ||
| Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review | Q37243135 | ||
| Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood | Q37344689 | ||
| Management of Kawasaki disease | Q37465500 | ||
| Takayasu arteritis in children and adolescents | Q37766382 | ||
| Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years | Q38113544 | ||
| Twenty-five years of European Union collaboration in ANCA-associated vasculitis research | Q38389839 | ||
| Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. | Q38497908 | ||
| Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). | Q39530208 | ||
| Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial | Q40216635 | ||
| Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease | Q40320689 | ||
| A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. | Q40471283 | ||
| Takayasu's arteritis in children | Q40747480 | ||
| A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies | Q42163521 | ||
| Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis | Q42963758 | ||
| Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients | Q43174047 | ||
| Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis | Q44419035 | ||
| Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP). | Q44821776 | ||
| The epidemiology of Takayasu arteritis in the UK. | Q45960747 | ||
| Biologic therapy in primary systemic vasculitis of the young. | Q45964920 | ||
| Elicitation of expert prior opinion: application to the mypan trial in childhood polyarteritis nodosa. | Q46004151 | ||
| Successful tocilizumab treatment in a child with refractory Takayasu arteritis. | Q48297576 | ||
| Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. | Q50958607 | ||
| Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases. | Q53790639 | ||
| Tocilizumab for the treatment of patients with refractory Takayasu arteritis. | Q54484812 | ||
| Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. | Q55055285 | ||
| Type I interferonopathies: a novel set of inborn errors of immunity | Q56923635 | ||
| Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides | Q58622171 | ||
| Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients | Q59400138 | ||
| Infliximab is Effective for Takayasu Arteritis Refractory to Glucocorticoid and Methotrexate | Q60809312 | ||
| Vasculitis in children | Q64049648 | ||
| Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospect | Q71561244 | ||
| Takayasu arteritis in children and young indians | Q74297354 | ||
| A Case Series of Adenosine Deaminase 2-deficient Patients Emphasizing Treatment and Genotype-phenotype Correlations | Q85696858 | ||
| Stimulator of interferon genes-associated vasculitis of infancy | Q86295164 | ||
| Rituximab or azathioprine maintenance in ANCA-associated vasculitis | Q86570079 | ||
| Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production | Q28114794 | ||
| Diagnosis, treatment, and long-term management of Kawasaki disease | Q28171298 | ||
| Infliximab treatment for refractory Kawasaki syndrome | Q28174813 | ||
| Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease | Q28219020 | ||
| 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides | Q28276589 | ||
| Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. | Q30359250 | ||
| Early-onset stroke and vasculopathy associated with mutations in ADA2 | Q30410263 | ||
| Renal replacement therapy in children: data from 12 registries in Europe | Q30886505 | ||
| Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood | Q33514010 | ||
| Etanercept plus standard therapy for Wegener's granulomatosis | Q33984596 | ||
| EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. | Q34111632 | ||
| Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins | Q34156325 | ||
| Activated STING in a vascular and pulmonary syndrome | Q34241214 | ||
| The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. | Q34289660 | ||
| Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis | Q34368484 | ||
| Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose | Q34452119 | ||
| Treatment of patients with the hypereosinophilic syndrome with mepolizumab | Q34762186 | ||
| The spectrum of vasculitis in children | Q34974956 | ||
| Rituximab versus cyclophosphamide for ANCA-associated vasculitis | Q35109118 | ||
| Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. | Q35354592 | ||
| Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa | Q35590334 | ||
| Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. | Q35754152 | ||
| Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature | Q36330059 | ||
| Childhood vasculitis and plasma exchange | Q36568515 | ||
| Time to share | Q36643032 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hormone | Q11364 |
| globulins | Q321710 | ||
| blood proteins | Q425056 | ||
| vasculitis | Q644318 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 26 | |
| P577 | publication date | 2016-04-26 | |
| P1433 | published in | Pediatric Rheumatology Online Journal | Q15756119 |
| P1476 | title | Therapeutic advances in the treatment of vasculitis | |
| P478 | volume | 14 |
| Q47787813 | ATS Core Curriculum 2017: Part II. Pediatric Pulmonary Medicine |
| Q48260256 | Comparing polyarteritis nodosa in children and adults: a single center study. |
| Q58770436 | Continuous infusion of lipo-prostaglandin E1 for Takayasu's arteritis with heart failure in an 11-month-old baby: a case report |
| Q52709504 | Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis. |
| Q90455679 | Kawasaki Disease |
| Q42010069 | Optic Neuropathy Secondary to Polyarteritis Nodosa, Case Report, and Diagnostic Challenges |
| Q38645654 | Vasculitis update: pathogenesis and biomarkers. |
| Q95361138 | [Hypertension and intermittent convulsions for one month in a school-age child] |
Search more.